secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lunai Bioworks Inc. (LNAI)
CIK:        0001527728
Form:       8-K
Filed at:   2024-03-13T23:59:59+00:00
Accession:  0001731122-24-000419
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Renovaro appoints Simon Tarsh as Interim CFO; outgoing CFO Puche departs
------------------------------------------------------------------------

- Simon Tarsh named Interim CFO effective March 11, 2024; replaces Ms. Puche who leaves after >5 years.
- Consulting agreement pays Tarsh PB Advisors $25,000/month plus up to 30% bonus on milestones.
- Bonuses tied to timely SEC filings and hiring a permanent CFO before agreement termination.
- Term is 6 months, renewable monthly; may be terminated by either party on 30 days' notice.
- Tarsh receives 10,000 stock options, vesting if a new CFO is hired prior to termination date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527728/000173112224000419/0001731122-24-000419-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527728/000173112224000419/e5493_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-24-000419

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer